-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VCKUIVYr4ZZOxcrBePOPpFKoMvm3jfKQnrwh1IMTAzWgdMVADuoL/mUkO7XvHH3p ejVv+h8uon8yXYrv/OO6kQ== 0001177254-06-000047.txt : 20060919 0001177254-06-000047.hdr.sgml : 20060919 20060919121308 ACCESSION NUMBER: 0001177254-06-000047 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060919 DATE AS OF CHANGE: 20060919 GROUP MEMBERS: CHAI TRUST COMPANY, L.L.C. GROUP MEMBERS: EGI-FUND (02-04) INVESTORS, L.L.C. GROUP MEMBERS: EGI-MANAGING MEMBER (02-04), L.L.C. GROUP MEMBERS: GAMI INVESTMENTS, INC. GROUP MEMBERS: GVI HOLDINGS, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adams Respiratory Therapeutics, Inc. CENTRAL INDEX KEY: 0001319439 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752725552 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80877 FILM NUMBER: 061097397 BUSINESS ADDRESS: STREET 1: 4 MILL RIDGE LANE CITY: CHESTER STATE: NJ ZIP: 07930 BUSINESS PHONE: (908) 879-1400 MAIL ADDRESS: STREET 1: 4 MILL RIDGE LANE CITY: CHESTER STATE: NJ ZIP: 07930 FORMER COMPANY: FORMER CONFORMED NAME: Adams Laboratories, Inc. DATE OF NAME CHANGE: 20050302 FORMER COMPANY: FORMER CONFORMED NAME: Adams Respiratory Therapeutics, Inc. DATE OF NAME CHANGE: 20050301 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SZ INVESTMENTS LLC CENTRAL INDEX KEY: 0001093566 IRS NUMBER: 364150443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: TWO NORTH RIVERSIDE PLAZA CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3124541800 MAIL ADDRESS: STREET 1: TWO NORTH RIVERSIDE PLAZA CITY: CHICAGO STATE: IL ZIP: 60606 SC 13D/A 1 amendmentfive.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 5)*

Adams Respiratory Therapeutics, Inc.

--------------------------------------------------------------------------------

(Name of Issuer)

Common Stock, $0.01 par value

--------------------------------------------------------------------------------

(Title of Class of Securities)

00635P 10 7

--------------------------------------------------------------------------------

(CUSIP Number)

Marc D. Hauser

Equity Group Investments, L.L.C.

2 North Riverside Plaza, Suite 600

Chicago, Illinois 60606

312-466-3281

--------------------------------------------------------------------------------

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

September 13, 2006

--------------------------------------------------------------------------------

(Date of Event which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [_].

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

EGI-Fund (02-04) Investors, L.L.C.

FEIN 40-0002819

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Delaware

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 848

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 848

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

848

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

Less than 0.1% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

(1) Based on 35,036,160 shares of Common Stock, par value $0.01 per share, outstanding as of September 12, 2006, based upon information contained in the Issuer's Prospectus Supplement dated September 14, 2006 and filed on September 15, 2006.

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

EGI-Managing Member (02-04), L.L.C.

FEIN 40-0002816

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Delaware

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 848

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 848

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

848

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

Less than 0.1% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

GAMI Investments, Inc.

FEIN 36-3992617

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Delaware

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 2,680

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 2,680

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

2,680

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

Less than 0.1% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

GVI Holdings, Inc.

FEIN 36-4081034

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Delaware

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 251,231

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 251,231

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

251,231

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

0.7% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

SZ Investments, L.L.C.

FEIN 36-4150443

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Delaware

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 3,199,315

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 3,199,315

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

3,199,315

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

9.1% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

_____________________________________________________________________________

1.	Name of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only).

Chai Trust Company, L.L.C.

FEIN 36-4268733

_____________________________________________________________________________

2.	Check the Appropriate Box If a Member of a Group (See Instructions)

(a) x

(b) [_]

_____________________________________________________________________________

3.	SEC Use Only

_____________________________________________________________________________

4.	Source of Funds (See Instructions)

_____________________________________________________________________________

5.	Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_]

_____________________________________________________________________________

6.	Citizenship or Place of Organization

Illinois

_____________________________________________________________________________

NUMBER OF

Sole Voting Power – 0

BENEFICIALLY

Shared Voting Power – 3,454,074

OWNED BY

EACH

Sole Dispositive Power - 0

REPORTING

PERSON

10.

Shared Dispositive Power – 3,454,074

WITH

_____________________________________________________________________________

11.	Aggregate Amount Beneficially Owned by Each Reporting Person

3,454,074

_____________________________________________________________________________

12.	Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares

(See Instructions) [_]

_____________________________________________________________________________

13.	Percent of Class Represented by Amount in Row (11)

9.9% (1)

_____________________________________________________________________________

14.	Type of Reporting Person (See Instructions)

_____________________________________________________________________________

CUSIP No. 00635P 10 7

SCHEDULE 13D/A

This Amendment No. 5 to Schedule 13D relates to the common stock, par value $0.01 per share ("Common Stock"), of Adams Respiratory Therapeutics, Inc., a Delaware corporation (the "Issuer"). Item 3 and 5 of the Schedule 13D are hereby amended as set forth below.

ITEM 3.

Source and Amount of Funds or Other Consideration.

Item 3 is hereby amended by appending the following thereto:

On September 13 and September 19, 2006, SZI sold an aggregate 1,725,000 shares of Common Stock in an underwritten public offering at a price of $38.21 per share, for total proceeds of $65,912,250.00 (the "September 06 Sale").

ITEM 5.

Interest in Securities of the Issuer.

Item 5 is hereby amended and restated in its entirety as follows:

(a) and (b) To the best knowledge of the Reporting Persons, there were 35,036,160 shares of Common Stock, par value $0.01 per share, outstanding as of September 12, 2006, based upon information contained in the Issuer's Prospectus Supplement dated September 14, 2006 and filed on September 15, 2006. As of September 19, 2006, after giving effect to the September 06 Sale, the aggregate 3,454,074 shares of Common Stock beneficially owned by the Reporting Persons represent approximately 9.9% of the Common Stock issued and outstanding. Such shares of Common Stock are held outright as follows:

•

848 shares of Common Stock held by EGI-02-04

•

2,680 shares of Common Stock held by GAMI

•

251,231 shares of Common Stock held by GVI

•

3,199,315 shares of Common Stock held by SZI

Beneficial ownership of such 3,454,074 shares of Common Stock is held as follows:

•

848 shares of Common Stock held by EGI-02-04

•

2,680 shares of Common Stock held by GAMI

•

251,231 shares of Common Stock held by GVI

•

3,199,315 shares of Common Stock held by SZI

•

3,454,074 shares of Common Stock beneficially owned by Chai

(c) Except as set forth above, during the last 60 days, no transactions in the Common Stock were effected by any Reporting Person, or to the best knowledge of any Reporting Person, any of the persons set forth in Item 2.

(d) No person other than a Stockholder has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of shares of Common Stock owned by such Stockholder.

(e)	Not applicable.

SIGNATURES

After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATED: September 19, 2006

SZ INVESTMENTS, L.L.C.

EGI-MANAGING MEMBER (02-04), L.L.C.

EGI-FUND (02-04) INVESTORS, L.L.C.

GVI HOLDINGS, INC.

GAMI INVESTMENTS, INC.

By: /s/ PHILIP G. TINKLER

-------------------------------------

Name: Philip G. Tinkler

Title: Vice President

CHAI TRUST COMPANY, L.L.C.

By: /s/ DONALD J. LIEBENTRITT

-------------------------------------

Name: Donald J. Liebentritt

Title: President

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)

-----END PRIVACY-ENHANCED MESSAGE-----